5/14
04:28 pm
lumo
Lumos Pharma Announces Positive End-of-Phase 2 Meeting with FDA and Reports First Quarter 2024 Financial Results [Yahoo! Finance]
High
Report
Lumos Pharma Announces Positive End-of-Phase 2 Meeting with FDA and Reports First Quarter 2024 Financial Results [Yahoo! Finance]
5/14
04:15 pm
lumo
Lumos Pharma Announces Positive End-of-Phase 2 Meeting with FDA and Reports First Quarter 2024 Financial Results
High
Report
Lumos Pharma Announces Positive End-of-Phase 2 Meeting with FDA and Reports First Quarter 2024 Financial Results
5/9
02:51 pm
lumo
Lumos Pharma to Report First Quarter 2024 Financial Results and Provide Clinical Update on May 15, 2024
Neutral
Report
Lumos Pharma to Report First Quarter 2024 Financial Results and Provide Clinical Update on May 15, 2024
4/18
04:05 pm
lumo
Lumos Pharma Announces Abstracts Accepted for Presentation at Upcoming Medical Meetings
Low
Report
Lumos Pharma Announces Abstracts Accepted for Presentation at Upcoming Medical Meetings
3/20
12:31 pm
lumo
Lumos Pharma, Inc. (NASDAQ: LUMO) had its "buy" rating re-affirmed by analysts at HC Wainwright. They now have a $28.00 price target on the stock.
Medium
Report
Lumos Pharma, Inc. (NASDAQ: LUMO) had its "buy" rating re-affirmed by analysts at HC Wainwright. They now have a $28.00 price target on the stock.
3/20
08:11 am
lumo
Lumos Pharma Announces that the USPTO Has Granted Patent Protection for Novel Formulation of LUM-201, Extending Exclusivity to 2042 [Yahoo! Finance]
High
Report
Lumos Pharma Announces that the USPTO Has Granted Patent Protection for Novel Formulation of LUM-201, Extending Exclusivity to 2042 [Yahoo! Finance]
3/20
08:00 am
lumo
Lumos Pharma Announces that the USPTO Has Granted Patent Protection for Novel Formulation of LUM-201, Extending Exclusivity to 2042
Medium
Report
Lumos Pharma Announces that the USPTO Has Granted Patent Protection for Novel Formulation of LUM-201, Extending Exclusivity to 2042
3/10
08:52 am
lumo
Lumos Pharma Full Year 2023 Earnings: Revenues Beat Expectations, EPS Lags [Yahoo! Finance]
Low
Report
Lumos Pharma Full Year 2023 Earnings: Revenues Beat Expectations, EPS Lags [Yahoo! Finance]
5/14/2024
04:15 pm
LUMO
lumos pharma, inc.
MISS
Report
-12.2%
lumos pharma, inc.
5/14/2024
04:15 pm
LUMO
lumos pharma, inc.
MISS
Report
-12.2%
lumos pharma, inc.
8/9/2023
04:01 pm
LUMO
lumos pharma, inc.
MISS
Report
-5.8%
lumos pharma, inc.
5/15
04:17 pm
lumo
Form 10-Q LUMOS PHARMA, INC. For: Mar 31
Medium
Report
Form 10-Q LUMOS PHARMA, INC. For: Mar 31
5/15
09:58 am
lumo
Form 8-K LUMOS PHARMA, INC. For: May 15
Low
Report
Form 8-K LUMOS PHARMA, INC. For: May 15
4/22
04:31 pm
lumo
Form 10-K/A LUMOS PHARMA, INC. For: Dec 31
Medium
Report
Form 10-K/A LUMOS PHARMA, INC. For: Dec 31
4/18
04:53 pm
lumo
Form 8-K LUMOS PHARMA, INC. For: Apr 18
Low
Report
Form 8-K LUMOS PHARMA, INC. For: Apr 18
4/15
04:34 pm
lumo
Form ARS LUMOS PHARMA, INC. For: Dec 31
Low
Report
Form ARS LUMOS PHARMA, INC. For: Dec 31
4/12
05:28 pm
lumo
Form DEFA14A LUMOS PHARMA, INC.
Medium
Report
Form DEFA14A LUMOS PHARMA, INC.
4/12
05:02 pm
lumo
Form DEF 14A LUMOS PHARMA, INC. For: Dec 31
Medium
Report
Form DEF 14A LUMOS PHARMA, INC. For: Dec 31
4/3
05:11 pm
lumo
Form 4 LUMOS PHARMA, INC. For: Apr 01 Filed by: Lawley Lori D
Low
Report
Form 4 LUMOS PHARMA, INC. For: Apr 01 Filed by: Lawley Lori D
News Stats
All News
News Wires
Media Monitoring
SEC Edgar Filings
Upgrades
Downgrades
Initiated
Reiterated
Last Earnings
Last Earnings EPS
Next Earnings
Order Stats
Sub-Penny
Odd lot
Avg. bid-ask spread
Avg. bid-ask size
Shares at ask/bid
Off exchange
Main News & Impact Reports
Don’t Miss Out On The Next BIG Stock Move
Never get left behind with our daily ‘Shakers & Movers’ newsletter. Discover the biggest gainer or loser in the stock market, and learn exactly WHY it moved. To find out which one caught Wall Street by surprise TODAY, sign up to our newsletter below:
Register